Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.54B |
| 2 |
ExxonMobil
XOM
|
+$905M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$791M |
| 4 |
Uber
UBER
|
+$725M |
| 5 |
Micron Technology
MU
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$735M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$718M |
| 4 |
Colgate-Palmolive
CL
|
+$406M |
| 5 |
Progressive
PGR
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.06% |
| 2 | Healthcare | 12.15% |
| 3 | Consumer Discretionary | 11.55% |
| 4 | Financials | 11.3% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Resources Connection
RGP
$129M
| $20.4K | ﹤0.01% |
1,848
-7,103
| -79% | -$79.9K |
|
1752
Replimune Group
REPL
$814M
| $20.3K | ﹤0.01% |
2,513
-245,567
| -99% | -$1.71M |
|
1753
CALL
Advantage Solutions
ADV
$484M
| $20.1K | ﹤0.01% |
248
| – | – |
|
1754
State Street SPDR S&P Insurance ETF
KIE
$619M
| $19.9K | ﹤0.01% |
400
| – | – |
|
1755
Hawaiian Electric Industries
HE
$2.33B
| $19.7K | ﹤0.01% |
2,317
-153,452
| -99% | -$1.59M |
|
1756
Olema Pharmaceuticals
OLMA
$1.02B
| $19.6K | ﹤0.01% |
+1,839
| New | +$19.9K |
|
1757
iShares Russell 2000 ETF
IWM
$80.9B
| $19.2K | ﹤0.01% |
95
| – | – |
|
1758
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
| $18.8K | ﹤0.01% |
190
| – | – |
|
1759
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $18.7K | ﹤0.01% |
35
| – | – |
|
1760
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $18.6K | ﹤0.01% |
320
| – | – |
|
1761
Lufax Holding
LU
$1.2B
| $17.9K | ﹤0.01% |
6,064
-45,208
| -88% | -$172K |
|
1762
Xponential Fitness
XPOF
$265M
| $17.7K | ﹤0.01% |
1,124
-994
| -47% | -$12.3K |
|
1763
Allogene Therapeutics
ALLO
$601M
| $16.7K | ﹤0.01% |
+8,011
| New | +$23.6K |
|
|
VERV
1764
DELISTED
Verve Therapeutics
VERV
| $16.5K | ﹤0.01% |
+3,208
| New | +$20.2K |
|
1765
Fate Therapeutics
FATE
$281M
| $15.8K | ﹤0.01% |
+4,990
| New | +$21.8K |
|
1766
Editas Medicine
EDIT
$399M
| $15.3K | ﹤0.01% |
3,294
| – | – |
|
1767
Petco
WOOF
$745M
| $14.2K | ﹤0.01% |
4,492
-3,206
| -42% | -$8.19K |
|
1768
Bally's
BALY
$672M
| $14K | ﹤0.01% |
1,175
-1,262
| -52% | -$16.1K |
|
1769
Designer Brands
DBI
$277M
| $13.9K | ﹤0.01% |
2,077
-21
| -1% | -$186 |
|
1770
MGIC Investment
MTG
$6.27B
| $13.8K | ﹤0.01% |
642
-493
| -43% | -$10.2K |
|
1771
Marcus Corp
MCS
$732M
| $12.7K | ﹤0.01% |
+1,137
| New | +$13.5K |
|
1772
H&R Block
HRB
$5.18B
| $11.7K | ﹤0.01% |
215
-46,827
| -100% | -$2.33M |
|
1773
Perdoceo Education
PRDO
$1.9B
| $11.3K | ﹤0.01% |
+527
| New | +$10.9K |
|
1774
iShares MSCI Europe Small-Cap ETF
IEUS
$175M
| $10.8K | ﹤0.01% |
188
| – | – |
|
1775
StoneCo
STNE
$2.62B
| $10.4K | ﹤0.01% |
857
-11,792
| -93% | -$174K |
|
Similar funds
Amundi's Q2 2024 Portfolio in Review
As of Q2 2024, Amundi held 2,114 positions worth $261B, up 12% from $233B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Amundi's Q2 2024 filing shows 127 new, 621 increased, 973 reduced and 191 closed positions. Its largest new stake was GE Vernova: 1,692,458 shares worth $292M. The largest sale was Meta Platforms (Facebook), an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q2 2024 buy was GE Vernova: 1,692,458 shares worth $292M.
- Amundi added most to Apple in Q2 2024, an estimated $1.54B increase.
- Amundi's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $1.51B.
- Amundi fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $207M.
- Amundi's ten largest holdings make up 27% of its $261B portfolio in Q2 2024.
- Amundi opened 127 new positions and closed 191 in Q2 2024.
- Amundi's portfolio value rose 12% quarter-over-quarter to $261B.
Based on Amundi's 13F filing for Q2 2024, filed 14 Aug 2024.